Encompass Health Corporation (EHC) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Win.
62/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseEHC / S&P 4.70% / 15.20% |
LoseEHC / S&P 9.47% / 15.00% |
LoseEHC / S&P 20.16% / 50.40% |
| 2026-Q10/3 |
LoseEHC / S&P -8.70% / -4.33% |
LoseEHC / S&P 10.05% / 11.30% |
LoseEHC / S&P 23.76% / 27.70% |
| 2025-Q42/3 |
LoseEHC / S&P -16.31% / 2.65% |
WinEHC / S&P 10.46% / 9.00% |
WinEHC / S&P 24.22% / 13.40% |
| 2025-Q32/3 |
LoseEHC / S&P 3.72% / 8.12% |
WinEHC / S&P 11.13% / 4.61% |
WinEHC / S&P 28.09% / 13.45% |
| 2025-Q23/3 |
WinEHC / S&P 21.28% / 10.94% |
WinEHC / S&P 11.80% / 4.83% |
WinEHC / S&P 30.69% / 10.63% |
| 2025-Q13/3 |
WinEHC / S&P 9.87% / -4.27% |
WinEHC / S&P 11.21% / 4.98% |
WinEHC / S&P 31.17% / 10.57% |
| 2024-Q42/3 |
LoseEHC / S&P -4.27% / 2.41% |
WinEHC / S&P 11.91% / 5.25% |
WinEHC / S&P 28.90% / 6.15% |
| 2024-Q33/3 |
WinEHC / S&P 12.84% / 5.89% |
WinEHC / S&P 11.15% / 5.89% |
WinEHC / S&P 18.00% / 6.11% |
| 2024-Q22/3 |
LoseEHC / S&P 3.89% / 4.28% |
WinEHC / S&P 10.86% / 5.38% |
WinEHC / S&P 25.72% / 5.12% |
| 2024-Q13/3 |
WinEHC / S&P 24.01% / 10.56% |
WinEHC / S&P 11.40% / 5.71% |
WinEHC / S&P 36.67% / 5.59% |
| 2023-Q42/3 |
LoseEHC / S&P -0.43% / 11.69% |
WinEHC / S&P 10.41% / 6.81% |
WinEHC / S&P 28.15% / 7.78% |
| 2023-Q33/3 |
WinEHC / S&P -0.59% / -3.27% |
WinEHC / S&P 10.29% / 7.52% |
WinEHC / S&P 28.68% / -5.03% |
| 2023-Q23/3 |
WinEHC / S&P 25.44% / 8.74% |
WinEHC / S&P 9.56% / 9.50% |
WinEHC / S&P -4.89% / -8.57% |
| 2023-Q10/3 |
LoseEHC / S&P -9.29% / 7.50% |
LoseEHC / S&P 1.12% / 10.77% |
LoseEHC / S&P -30.95% / -15.69% |
| 2022-Q41/3 |
WinEHC / S&P 32.57% / 7.56% |
LoseEHC / S&P -4.87% / 11.88% |
LoseEHC / S&P -34.31% / -17.99% |
| 2022-Q32/3 |
WinEHC / S&P 2.36% / -4.88% |
WinEHC / S&P 16.06% / 13.47% |
LoseEHC / S&P -33.00% / -1.41% |
| 2022-Q20/3 |
LoseEHC / S&P -21.18% / -16.10% |
LoseEHC / S&P 9.06% / 13.71% |
LoseEHC / S&P -14.84% / 11.04% |
| 2022-Q12/3 |
WinEHC / S&P 9.39% / -4.60% |
WinEHC / S&P 21.73% / 15.97% |
LoseEHC / S&P 28.20% / 42.23% |
| 2021-Q41/3 |
LoseEHC / S&P -12.66% / 11.03% |
WinEHC / S&P 28.18% / 15.00% |
LoseEHC / S&P 44.21% / 96.40% |
| 2021-Q30/3 |
LoseEHC / S&P -3.48% / 0.58% |
LoseEHC / S&P -20.57% / 10.77% |
LoseEHC / S&P 52.06% / 69.42% |
| 2021-Q20/3 |
LoseEHC / S&P -4.39% / 8.55% |
LoseEHC / S&P -16.81% / 6.58% |
LoseEHC / S&P 33.80% / 51.81% |
| 2021-Q10/3 |
LoseEHC / S&P -0.62% / 6.17% |
LoseEHC / S&P -22.48% / -1.06% |
LoseEHC / S&P -11.59% / 7.39% |
| 2020-Q42/3 |
WinEHC / S&P 27.69% / 12.15% |
LoseEHC / S&P -22.56% / -3.72% |
WinEHC / S&P -21.05% / -33.42% |
| 2020-Q32/3 |
LoseEHC / S&P 5.39% / 8.93% |
WinEHC / S&P 2.17% / -2.04% |
WinEHC / S&P -16.82% / -27.10% |
| 2020-Q22/3 |
LoseEHC / S&P -2.83% / 20.54% |
WinEHC / S&P 4.06% / -0.46% |
WinEHC / S&P -8.01% / -27.11% |
| 2020-Q13/3 |
WinEHC / S&P -7.15% / -19.60% |
WinEHC / S&P 7.06% / 3.47% |
WinEHC / S&P 10.58% / -14.75% |
| 2019-Q43/3 |
WinEHC / S&P 9.91% / 9.07% |
WinEHC / S&P 7.66% / 5.36% |
WinEHC / S&P 23.21% / 2.99% |
| 2019-Q31/3 |
LoseEHC / S&P 0.33% / 1.70% |
WinEHC / S&P 7.79% / 5.02% |
LoseEHC / S&P -5.87% / 0.21% |
| 2019-Q22/3 |
WinEHC / S&P 8.97% / 4.30% |
WinEHC / S&P 7.76% / 6.64% |
LoseEHC / S&P -2.19% / 8.65% |
| 2019-Q11/3 |
LoseEHC / S&P -4.91% / 13.65% |
WinEHC / S&P 8.81% / 8.12% |
LoseEHC / S&P 5.05% / 14.29% |
| 2018-Q40/3 |
LoseEHC / S&P -20.50% / -13.52% |
LoseEHC / S&P EHC unavailable / 9.05% |
LoseEHC / S&P 3.53% / 18.23% |
| 2018-Q32/3 |
WinEHC / S&P 15.51% / 7.71% |
LoseEHC / S&P EHC unavailable / 10.21% |
WinEHC / S&P 23.55% / 19.06% |
| 2018-Q22/3 |
WinEHC / S&P 18.89% / 3.43% |
LoseEHC / S&P EHC unavailable / 9.03% |
WinEHC / S&P 16.85% / 14.46% |
| 2018-Q11/3 |
WinEHC / S&P 16.21% / -0.76% |
LoseEHC / S&P EHC unavailable / 7.68% |
LoseEHC / S&P 10.82% / 12.46% |
| 2017-Q41/3 |
WinEHC / S&P 7.14% / 6.64% |
LoseEHC / S&P EHC unavailable / 7.03% |
LoseEHC / S&P 9.27% / 13.82% |
| 2017-Q30/3 |
LoseEHC / S&P -3.72% / 4.48% |
LoseEHC / S&P EHC unavailable / 5.68% |
LoseEHC / S&P 15.00% / 17.57% |
| 2017-Q22/3 |
WinEHC / S&P 13.61% / 3.09% |
LoseEHC / S&P EHC unavailable / 4.83% |
WinEHC / S&P 19.74% / 17.74% |
| 2017-Q11/3 |
LoseEHC / S&P 4.40% / 6.07% |
LoseEHC / S&P EHC unavailable / 3.67% |
WinEHC / S&P 28.85% / 13.32% |
| 2016-Q41/3 |
LoseEHC / S&P 2.24% / 3.82% |
LoseEHC / S&P EHC unavailable / 2.09% |
WinEHC / S&P 35.60% / 7.05% |
| 2016-Q32/3 |
WinEHC / S&P 5.12% / 3.85% |
LoseEHC / S&P EHC unavailable / 0.20% |
WinEHC / S&P 29.73% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | EHC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -1.10% | 20.78% |
| Annualized return | -1.10% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | EHC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 98.87% | 83.14% |
| Annualized return | 14.74% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | EHC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 330.33% | 319.30% |
| Annualized return | 15.71% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |